恶性高热的临床和形态学特征:一例来自实践的罕见病例
- 作者: Anichkov N.M.1, Kalinina E.Y.1, Davydova Z.V.1, Shcherbakova E.V.2, Yagmurov O.D.3
-
隶属关系:
- Saint-Petersburg State Pediatric Medical University
- Bureau of Forensic Medical Examination of the Leningrad region
- St. Petersburg Bureau of Forensic Medical Examination
- 期: 卷 8, 编号 4 (2022)
- 页面: 97-104
- 栏目: CASE REPORTS
- URL: https://journals.rcsi.science/2411-8729/article/view/122482
- DOI: https://doi.org/10.17816/fm733
- ID: 122482
如何引用文章
全文:
详细
现代全身麻醉最严重的并发症之一是恶性高热,表型表现为高碳酸血症、窦性心动过速、骨骼肌代谢亢进和横纹肌溶解或在使用吸入麻醉剂和非去极化肌肉松弛剂进行全身麻醉后。恶性高热症最常见的初始迹象是呼气结束时二氧化碳浓度突然上升。这种药物遗传性疾病的非典型形式比暴发性形式更常见。在俄罗斯恶性高热症的问题目前仍未得到解决。
作者描述了一例19岁女孩的恶性高热,她在使用西维兰麻醉下接受了鼻腔呼吸障碍的手术。由于出现了临床诊断的恶性高热,患者在离开麻醉状态1小时25分钟后死亡。法医尸检证实了这一诊断。使用观察性和选择性的组织学染色来描述骨骼肌的形态学变化。
所提出的观察值是由于雷电引起的恶性高热症的罕见性和伴随这些病理变体的高死亡率。这个专家案例展示了一个合格的、全面的组织学检查,包括使用基因测试,可以正确制定诊断,并在必要时对执法当局的问题作出合理的回应。
作者简介
Nikolai M. Anichkov
Saint-Petersburg State Pediatric Medical University
Email: anichkov@bk.ru
ORCID iD: 0000-0003-1834-7881
SPIN 代码: 5222-7003
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, 2, Litovskay street, Saint-Peterburg, 194100Elena Yu. Kalinina
Saint-Petersburg State Pediatric Medical University
Email: drkalinina@yandex.ru
ORCID iD: 0000-0001-7077-3584
SPIN 代码: 1176-5739
MD, Cand. Sci. (Med.)
俄罗斯联邦, 2, Litovskay street, Saint-Peterburg, 194100Zlata V. Davydova
Saint-Petersburg State Pediatric Medical University
编辑信件的主要联系方式.
Email: zlata.davydova@rambler.ru
ORCID iD: 0000-0002-6673-8230
SPIN 代码: 7016-7086
MD, Cand. Sci. (Med.)
俄罗斯联邦, 2, Litovskay street, Saint-Peterburg, 194100Ekaterina V. Shcherbakova
Bureau of Forensic Medical Examination of the Leningrad region
Email: maestrovody@mail.ru
ORCID iD: 0000-0002-3818-1535
SPIN 代码: 7685-0130
俄罗斯联邦, Saint Petersburg
Oraz D. Yagmurov
St. Petersburg Bureau of Forensic Medical Examination
Email: oraz.yagmurov@gmail.com
ORCID iD: 0000-0003-1822-6043
SPIN 代码: 7765-8978
MD, Dr. Sci. (Med.)
俄罗斯联邦, Saint Petersburg参考
- Lawal TA, Wires ES, Terry NL, et al. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990–2019. Orphanet J Rare Dis. 2020;15(1):113. doi: 10.1186/s13023-020-01384-x
- Gong X. Malignant hyperthermia when dantrolene is not readily available. BMC Anesthesiol. 2021;21(1):119. doi: 10.1186/s12871-021-01328-3
- Yang L, Tautz T, Zhang S, et al. The current status of malignant hyperthermia. J Biomed Res. 2020;34(2):75–85. doi: 10.7555/JBR.33.20180089
- Knuiman GJ, Küsters B, Eshuis L, et al. The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations. J Neurol. 2019;266(4):876–887. doi: 10.1007/s00415-019-09209-z
- Chang L, Daly C, Miller DM, et al. Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia-susceptible individuals. Br J Anaesth. 2019;122(5):613–621. doi: 10.1016/j.bja.2019.02.010
- Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994;80(4):771–779. doi: 10.1097/00000542-199404000-00008
- Lie JT, Holley KF, Kampa WR, et al. New histochemical method for morphologic diagnosis of early stages of myocardial ischemia. Proc Mayo Clin.1971;46(5):319–327.
补充文件
![](/img/style/loading.gif)